Tumor evolution studies involving the sequencing of paired initial and recurrent IDH-mutant tumors have suggested that mutation of the IDH gene is an early event in tumor formation [16,17], and the mutation indirectly alters the level of lipid synthesis [18,19]. The gene discussed is IDH1; the disease is neoplasm.